⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1191611 | 0.84 | SLC22A6 (0.36) | — | |
| Auriclosene SCHEMBL994601 | 0.84 | — | — | |
| Auriclosene SCHEMBL1537304 | 0.82 | — | — | |
| SCHEMBL2866753 | 0.70 | — | — | |
| SCHEMBL3379316 | 0.70 | CYP1A2 (0.32) | — | |
| SCHEMBL2870636 | 0.69 | PTGS1 (0.31) | — | |
| Tetrabuthylammonium SCHEMBL4167461 | 0.69 | SLC22A1 (0.40) | — | |
| Auriclosene SCHEMBL1537297 | 0.69 | TP53 (0.30) | — | |
| SCHEMBL20893589 | 0.69 | — | — | |
| SCHEMBL3381791 | 0.69 | SLC22A6 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2531026-A1 | POLYSACCHARIDE BASED ANTIMICROBIAL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2012-12-12 | — | — | EP | disclosed |
| WO-2011097324-A1 | POLYSACCHARIDE BASED ANTIMICROBIAL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2011-08-11 | — | — | WO | disclosed |